Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
ROCKVILLE, Md. (AP) _ Supernus Pharmaceuticals Inc. (SUPN) on Tuesday reported net income of $1.7 million in its third quarter.
On a per-share basis, the Rockville, Maryland-based company said it had net income of 3 cents.
The drugmaker posted revenue of $177.4 million in the period.
Supernus expects full-year revenue in the range of $650 million to $680 million.
Insight by LexisNexis: During this exclusive webinar, moderator Jason Miller will discuss management strategies driving workplace evolution with agency and industry leaders.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SUPN at https://www.zacks.com/ap/SUPN
© 2022 . All rights reserved. This website is not intended for users located within the European Economic Area.